Medtech Archives - Page 12 of 114 - Boston Life Sciences Times

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

December 11, 2025

Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells

December 9, 2025

Entrepreneur of the Year Award Honors Dermatology Innovator Reid Waldman, M.D.

December 8, 2025

THIS WEEK'S STORIES

Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, Expanding Rare Disease Portfolio

December 8, 2025

Amylyx Pharmaceuticals Reports New Cohort 1 Safety Data for AMX0114 in ALS from First-in-Human LUMINA Trial

December 5, 2025

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

December 11, 2025

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Medtech

Vektor Medical receives FDA 510(k) clearance expanding vMap’s non-invasive cardiac mapping capabilities

Owlet Launches TGA-Approved Dream Sock in Australia and New Zealand, Expanding Global Reach of Pediatric Health Monitoring

Valvosoft, the First Non-Invasive Treatment for Severe Symptomatic Aortic Stenosis, Receives CE Marking

Aptyx Expands With New Precision Extrusion Center of Excellence in Boston Medtech Corridor

Insulet Announces FDA Clearance for Major Omnipod 5 Algorithm Upgrades

Most Read

Sunoh.ai joins athenahealth Marketplace to expand access to AI-driven clinical documentation

Phare Bio and Basilea form partnership to develop AI-designed broad-spectrum antibiotic

Suffolk hires Roger Moore to strengthen healthcare construction leadership in California

Survey shows healthcare experts fear AI will accelerate online medical misinformation

EDITOR PICKS

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

Study Links Tumor Metabolism to Drug Binding Behavior in Live Cancer Cells

Entrepreneur of the Year Award Honors Dermatology Innovator Reid Waldman, M.D.

THIS WEEK'S STORIES

Mirum Pharmaceuticals to Acquire Bluejay Therapeutics, Expanding Rare Disease Portfolio

Amylyx Pharmaceuticals Reports New Cohort 1 Safety Data for AMX0114 in ALS from First-in-Human LUMINA Trial

Prilenia and Ferrer gain FDA approval to launch Phase 3 ALS study of pridopidine

POPULAR CATEGORY

ABOUT US

FOLLOW US